172 related articles for article (PubMed ID: 21371451)
1. The effect of a platelet cholesterol modulation on the acetylsalicylic acid-mediated blood platelet inhibition in hypercholesterolemic patients.
Luzak B; Boncler M; Rywaniak J; Wilk R; Stanczyk L; Czyz M; Rysz J; Watala C
Eur J Pharmacol; 2011 May; 658(2-3):91-7. PubMed ID: 21371451
[TBL] [Abstract][Full Text] [Related]
2. Pravastatin and simvastatin improves acetylsalicylic acid-mediated in vitro blood platelet inhibition.
Luzak B; Rywaniak J; Stanczyk L; Watala C
Eur J Clin Invest; 2012 Aug; 42(8):864-72. PubMed ID: 22409214
[TBL] [Abstract][Full Text] [Related]
3. Effect of atorvastatin on platelet thromboxane A(2) synthesis in aspirin-treated patients with acute myocardial infarction.
Santos MT; Fuset MP; Ruano M; Moscardó A; Valles J
Am J Cardiol; 2009 Dec; 104(12):1618-23. PubMed ID: 19962464
[TBL] [Abstract][Full Text] [Related]
4. Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients.
Sanguigni V; Pignatelli P; Lenti L; Ferro D; Bellia A; Carnevale R; Tesauro M; Sorge R; Lauro R; Violi F
Circulation; 2005 Feb; 111(4):412-9. PubMed ID: 15687128
[TBL] [Abstract][Full Text] [Related]
5. Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.
Tetik S; Ak K; Isbir S; Eksioglu-Demiralp E; Arsan S; Iqbal O; Yardimci T
Clin Appl Thromb Hemost; 2010 Apr; 16(2):189-98. PubMed ID: 19703819
[TBL] [Abstract][Full Text] [Related]
6. Increased superoxide anion production by platelets in hypercholesterolemic patients.
Sanguigni V; Pignatelli P; Caccese D; Pulcinelli FM; Lenti L; Magnaterra R; Martini F; Lauro R; Violi F
Thromb Haemost; 2002 May; 87(5):796-801. PubMed ID: 12038779
[TBL] [Abstract][Full Text] [Related]
7. Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolemic subjects.
Puccetti L; Bruni F; Bova G; Cercignani M; Palazzuoli A; Console E; Auteri A; Pasqui AL
Nutr Metab Cardiovasc Dis; 2001 Dec; 11(6):378-87. PubMed ID: 12055702
[TBL] [Abstract][Full Text] [Related]
8. Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets?
Piorkowski M; Fischer S; Stellbaum C; Jaster M; Martus P; Morguet AJ; Schultheiss HP; Rauch U
J Am Coll Cardiol; 2007 Mar; 49(10):1035-42. PubMed ID: 17349882
[TBL] [Abstract][Full Text] [Related]
9. Atorvastatin reduces platelet-oxidized-LDL receptor expression in hypercholesterolaemic patients.
Puccetti L; Sawamura T; Pasqui AL; Pastorelli M; Auteri A; Bruni F
Eur J Clin Invest; 2005 Jan; 35(1):47-51. PubMed ID: 15638819
[TBL] [Abstract][Full Text] [Related]
10. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
Baldassarre S; Scruel O; Deckelbaum RJ; Dupont IE; Ducobu J; Carpentier YA
Int J Cardiol; 2005 Oct; 104(3):338-45. PubMed ID: 16186066
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory effect of statins on urinary 11-dehydrothromboxane levels.
Alusik S; Paluch Z; Lejsková M; Adámek T
Int Angiol; 2010 Jun; 29(3):255-9. PubMed ID: 20502413
[TBL] [Abstract][Full Text] [Related]
12. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
[TBL] [Abstract][Full Text] [Related]
13. Effect of atorvastatin upon platelet activation in hypercholesterolemia, evaluated by flow cytometry.
Labiós M; Martínez M; Gabriel F; Guiral V; Martínez E; Aznar J
Thromb Res; 2005; 115(4):263-70. PubMed ID: 15668185
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
[TBL] [Abstract][Full Text] [Related]
15. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
[TBL] [Abstract][Full Text] [Related]
16. Gender differences in short-term effects of atorvastatin on lipid profile, fibrinolytic parameters, and endothelial function.
Sakabe K; Fukuda N; Fukuda Y; Wakayama K; Nada T; Morishita S; Shinohara H; Tamura Y
Nutr Metab Cardiovasc Dis; 2008 Mar; 18(3):182-8. PubMed ID: 17399968
[TBL] [Abstract][Full Text] [Related]
17. The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes.
Mitsios JV; Papathanasiou AI; Elisaf M; Goudevenos JA; Tselepis AD
Platelets; 2005 Aug; 16(5):287-92. PubMed ID: 16011979
[TBL] [Abstract][Full Text] [Related]
18. Reduction of platelet cytosolic phospholipase A2 activity by atorvastatin and simvastatin: biochemical regulatory mechanisms.
Moscardó A; Vallés J; Latorre A; Madrid I; Santos MT
Thromb Res; 2013 Apr; 131(4):e154-9. PubMed ID: 23352311
[TBL] [Abstract][Full Text] [Related]
19. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia.
Koter M; Broncel M; Chojnowska-Jezierska J; Klikczynska K; Franiak I
Eur J Clin Pharmacol; 2002 Nov; 58(8):501-6. PubMed ID: 12451426
[TBL] [Abstract][Full Text] [Related]
20. Time course differences for statin-induced pleiotropic effects in hypercholesterolemic patients.
Sakabe K; Fukuda N; Wakayama K; Nada T; Shinohara H; Tamura Y
Int J Cardiol; 2004 Mar; 94(1):111-7. PubMed ID: 14996484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]